BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7630185)

  • 1. Waldenström's macroglobulinemia with the AML/MDS-associated t(1;3)(p36;q21).
    Johansson B; Waldenström J; Hasselblom S; Mitelman F
    Leukemia; 1995 Jul; 9(7):1136-8. PubMed ID: 7630185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and laboratory study of 4 cases of myelodysplastic syndromes with t (1;3) (p36; q21)].
    Zhang MR; Liu XP; Zhang Y; Yang L; Zhou XH; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):99-102. PubMed ID: 16732963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
    Li S; Yin CC; Medeiros LJ; Bueso-Ramos C; Lu G; Lin P
    Am J Clin Pathol; 2012 Jul; 138(1):146-52. PubMed ID: 22706870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1.
    Xinh PT; Tri NK; Nagao H; Nakazato H; Taketazu F; Fujisawa S; Yagasaki F; Chen YZ; Hayashi Y; Toyoda A; Hattori M; Sakaki Y; Tokunaga K; Sato Y
    Genes Chromosomes Cancer; 2003 Mar; 36(3):313-6. PubMed ID: 12557231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome.
    Glassman AB; Hayes KJ
    Ann Clin Lab Sci; 2003; 33(3):285-8. PubMed ID: 12956443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
    Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P
    Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenström's macroglobulinemia after sequential treatment with chlorambucil and fludarabine.
    Shin SJ; Chun SH; Kim KO; Kim MK; Lee KH; Hyun MS; Cho HS
    Jpn J Clin Oncol; 2005 Oct; 35(10):622-5. PubMed ID: 16172172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).
    Xiao Z; Zhang M; Liu X; Zhang Y; Yang L; Hao Y
    Leuk Res; 2006 Mar; 30(3):332-4. PubMed ID: 16102824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
    Estey E; Trujillo JM; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich EJ; Stass S
    Hematol Pathol; 1992; 6(1):43-8. PubMed ID: 1601822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly.
    Liu YC; Miyazawa K; Sashida G; Kodama A; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Aug; 169(1):69-72. PubMed ID: 16875940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic significance of t(1;3)(p36;q21) in the disorders of hematopoiesis.
    Welborn JL; Lewis JP; Jenks H; Walling P
    Cancer Genet Cytogenet; 1987 Oct; 28(2):277-85. PubMed ID: 3476187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
    Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
    Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
    Lin P; Medeiros LJ; Yin CC; Abruzzo LV
    Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutional t(5;7)(q11;p15) rearranged to acquire monosomy 7q and trisomy 1q in a patient with myelodysplastic syndrome transforming to acute myelocytic leukemia.
    Ganly P; McDonald M; Spearing R; Morris CM
    Cancer Genet Cytogenet; 2004 Mar; 149(2):125-30. PubMed ID: 15036888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukemia associated with t(1;3)(p36;q21) and extreme thrombocytosis: a clinical study with literature review.
    Lim G; Kim MJ; Oh SH; Cho SY; Lee HJ; Suh JT; Lee J; Lee WI; Cho KS; Park TS
    Cancer Genet Cytogenet; 2010 Dec; 203(2):187-92. PubMed ID: 21156232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hornerin gene was involved in a case of acute myeloid leukemia transformed from myelodysplastic syndrome with t(1;2)(q21;q37).
    Wang L; Wang YY; Cao Q; Chen Z; Chen SJ
    Leukemia; 2006 Dec; 20(12):2184-7. PubMed ID: 17051244
    [No Abstract]   [Full Text] [Related]  

  • 20. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.
    Duhoux FP; Ameye G; Montano-Almendras CP; Bahloula K; Mozziconacci MJ; Laibe S; Wlodarska I; Michaux L; Talmant P; Richebourg S; Lippert E; Speleman F; Herens C; Struski S; Raynaud S; Auger N; Nadal N; Rack K; Mugneret F; Tigaud I; Lafage M; Taviaux S; Roche-Lestienne C; Latinne D; Libouton JM; Demoulin JB; Poirel HA; ;
    Br J Haematol; 2012 Jan; 156(1):76-88. PubMed ID: 22050763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.